# Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device

Study · id `cardio:ct-nct03965975` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03965975](<https://clinicaltrials.gov/study/NCT03965975>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03965975

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Heart failure; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.

## Technical summary

Registry record NCT03965975. Allocation not applicable; no masking; primary purpose diagnostic. Start 2019-06-10 (actual); primary completion 2020-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 700 participants (planned count; ClinicalTrials.gov record NCT03965975, source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)
- Started: 2019-06-10 (actual) (ClinicalTrials.gov record NCT03965975, source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)
- Primary completion: 2020-03 (anticipated) (ClinicalTrials.gov record NCT03965975, source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)
- Completion: 2020-03 (anticipated) (ClinicalTrials.gov record NCT03965975, source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03965975, source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03965975-2019-12-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device
- Acronym: STSD-2019-001
- Condition: Renal Insufficiency, Chronic
- Condition: Heart Failure
- Condition: Diabete Mellitus
- Condition: Diabetes; Nephropathy (Manifestation)
- Condition: Hematuria
- Condition: Urinary Tract Infections
- Intervention (Device): Lab Gold Standard
- Intervention (Device): S-There
- Lead sponsor: S-There Technologies SL
- Lead sponsor class: INDUSTRY
- Collaborator: Biobizkaia Health Research Institute
- Collaborator class: OTHER\_GOV
- Collaborator: Hospital de Cruces
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

## Provenance

Content hash: 46da7fc45023d3579d0f35d36bb42e371b7641f671869862a3711a5a6264ad58
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
